1. Home
  2. NKTR vs MTA Comparison

NKTR vs MTA Comparison

Compare NKTR & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • MTA
  • Stock Information
  • Founded
  • NKTR 1990
  • MTA 1983
  • Country
  • NKTR United States
  • MTA Canada
  • Employees
  • NKTR N/A
  • MTA N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • NKTR Health Care
  • MTA
  • Exchange
  • NKTR Nasdaq
  • MTA Nasdaq
  • Market Cap
  • NKTR 247.9M
  • MTA 264.7M
  • IPO Year
  • NKTR 1994
  • MTA N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • MTA $2.60
  • Analyst Decision
  • NKTR Buy
  • MTA
  • Analyst Count
  • NKTR 3
  • MTA 0
  • Target Price
  • NKTR $4.00
  • MTA N/A
  • AVG Volume (30 Days)
  • NKTR 2.2M
  • MTA 442.7K
  • Earning Date
  • NKTR 11-07-2024
  • MTA 11-14-2024
  • Dividend Yield
  • NKTR N/A
  • MTA N/A
  • EPS Growth
  • NKTR N/A
  • MTA N/A
  • EPS
  • NKTR N/A
  • MTA N/A
  • Revenue
  • NKTR $93,137,000.00
  • MTA $5,048,000.00
  • Revenue This Year
  • NKTR $12.85
  • MTA $44.57
  • Revenue Next Year
  • NKTR N/A
  • MTA $126.18
  • P/E Ratio
  • NKTR N/A
  • MTA N/A
  • Revenue Growth
  • NKTR 5.53
  • MTA 28.55
  • 52 Week Low
  • NKTR $0.47
  • MTA $2.32
  • 52 Week High
  • NKTR $1.93
  • MTA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 33.04
  • MTA 30.99
  • Support Level
  • NKTR $0.89
  • MTA $2.62
  • Resistance Level
  • NKTR $1.04
  • MTA $2.85
  • Average True Range (ATR)
  • NKTR 0.07
  • MTA 0.13
  • MACD
  • NKTR -0.00
  • MTA -0.01
  • Stochastic Oscillator
  • NKTR 14.81
  • MTA 3.74

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: